€38.00
GHRH Peptide
No
Monitoring of IGF-1 levels may be used to assess efficacy
TH9507
International Warehouse 3
Typically no significant impact on blood pressure
Egrifta
Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F)
(trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl
C221H366N72O67S
Peptide hormone
Growth hormone-releasing hormone (GHRH) analog
Approximately 38 minutes
2 mg injected subcutaneously once daily
Not applicable as it is not typically used for sports enhancement
Increases natural production of growth hormone
Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels
Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy
Beligas
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your Rating Rate… Perfect Good Average Not that bad Very Poor
Your Review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
There are no reviews yet.